These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 19756468)

  • 1. [Diagnostic and differential diagnosis of benign prostate syndrome (BPS): guidelines of the German Urologists].
    Berges R; Dreikorn K; Höfner K; Madersbacher S; Michel MC; Muschter R; Oelke M; Reich O; Rulf W; Tschuschke C; Tunn U
    Urologe A; 2009 Nov; 48(11):1356-60, 1362-4. PubMed ID: 19756468
    [No Abstract]   [Full Text] [Related]  

  • 2. [Latest trends and recommendations on epidemiology, diagnosis, and treatment of benign prostatic hyperplasia (BPH)].
    Gabuev A; Oelke M
    Aktuelle Urol; 2011 May; 42(3):167-78. PubMed ID: 21604233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [S2e guideline of the German urologists: Instrumental treatment of benign prostatic hyperplasia].
    Bschleipfer T; Bach T; Berges R; Dreikorn K; Gratzke C; Madersbacher S; Michel MS; Muschter R; Oelke M; Reich O; Tschuschke C; Höfner K
    Urologe A; 2016 Feb; 55(2):195-207. PubMed ID: 26518304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [S2e guideline of the German urologists: Conservative and pharmacologic treatment of benign prostatic hyperplasia].
    Höfner K; Bach T; Berges R; Dreikorn K; Gratzke C; Madersbacher S; Michel MS; Muschter R; Oelke M; Reich O; Tschuschke C; Bschleipfer T
    Urologe A; 2016 Feb; 55(2):184-94. PubMed ID: 26518303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial comment on: diagnostic accuracy of noninvasive tests to evaluate bladder outlet obstruction in men: detrusor wall thickness, uroflowmetry, postvoid residual urine, and prostate volume.
    Gratzke C; Reich O
    Eur Urol; 2007 Sep; 52(3):835. PubMed ID: 17207917
    [No Abstract]   [Full Text] [Related]  

  • 6. Differentiation between neurogenic and prostatic obstruction using the intraprostatic spiral. A case report.
    Ovesen H; Poulsen AL; Nordling J
    Scand J Urol Nephrol; 1990; 24(3):179-80. PubMed ID: 1700470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of intravesical prostatic protrusion and resistive index is useful to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Suzuki T; Otsuka A; Ozono S
    Int J Urol; 2016 Nov; 23(11):929-933. PubMed ID: 27545297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign prostatic hyperplasia.
    Lepor H
    J Urol; 1995 May; 153(5):1540-2. PubMed ID: 7536264
    [No Abstract]   [Full Text] [Related]  

  • 9. Transurethral incision of prostate compared with transurethral resection of prostate in 132 matching cases.
    Orandi A
    J Urol; 1987 Oct; 138(4):810-5. PubMed ID: 2443728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can noninvasive evaluation of benign prostatic obstruction be optimized?
    Løvvik A; Yaqub S; Oustad H; Sand TE; Nitti VW
    Curr Opin Urol; 2012 Jan; 22(1):1-6. PubMed ID: 22080874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real life practice in the management of benign prostatic hyperplasia.
    Naderi N; Mochtar CA; de la Rosette JJ
    Curr Opin Urol; 2004 Jan; 14(1):41-4. PubMed ID: 15091049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic scale of infravesical obstruction in patients d with benign prostatic hyperplasia].
    Aboian IA; Golovko SIu; Khitar'ian AG; Levin EG; Pavlov SV
    Urol Nefrol (Mosk); 1998; (6):32-7. PubMed ID: 10051826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of symptom score, quality of life score, maximal urinary flow rate, residual volume and prostate size for the diagnosis of obstructive benign prostatic hyperplasia: a urodynamic analysis.
    van Venrooij GE; Boon TA
    J Urol; 1996 Jun; 155(6):2014-8. PubMed ID: 8618311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does anamnestic symptom evaluation or clinical examination give enough information to evaluate the severity of obstruction in benign prostatic hyperplasia?
    Waldén M; Geirsson G; Pettersson S; Schäfer W; Dahlstrand C
    Scand J Urol Nephrol; 1995 Dec; 29(4):469-76. PubMed ID: 8719365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of urodynamic investigation in the assessment of benign prostatic hypertrophy.
    McGuire EJ
    J Urol; 1992 Oct; 148(4):1133-6. PubMed ID: 1383572
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of benign prostatic hyperplasia.
    Barry M; Roehrborn C
    Annu Rev Med; 1997; 48():177-89. PubMed ID: 9046954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why pressure-flow studies should be optional and not mandatory studies for evaluating men with benign prostatic hyperplasia.
    McConnell JD
    Urology; 1994 Aug; 44(2):156-8. PubMed ID: 7519379
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluating lower urinary tract symptoms suggestive of benign prostatic obstruction.
    Abrams P
    Scand J Urol Nephrol Suppl; 1999; 203():1-7. PubMed ID: 10636562
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment on: Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.
    Bachmann A
    Eur Urol; 2008 Oct; 54(4):908-9. PubMed ID: 18502568
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial comment on: Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.
    Seitz M
    Eur Urol; 2008 Oct; 54(4):909-10. PubMed ID: 18502567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.